AZN icon

AstraZeneca
AZN

185.95 USD
+4.15
2.28%
At close Updated Jun 5, 4:00 PM EDT
Pre-market
After hours
186.45
+0.50
0.27%
1 day
2.28%
5 days
1.77%
1 month
2.6%
3 months
-5.86%
6 months
106.2%
Year to date
103.07%
1 year
157.01%
5 years
229.7%
10 years
522.53%
 

About: A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Employees: 96,100

Healthcare Drug Manufacturers - General
0
Funds holding %
of 8,076 funds
Explore Fund Trends
0
Positive news %
of 37 articles
Check Journalist POV
Price charts implemented using Lightweight Charts™